Should you buy Abbott Labs stock hand over fist before July 16?

July earnings matter, but long-term growth matters more.

Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy

Abbott Laboratories (NYSE:ABT) at $90.53 is a Buy. The healthcare giant has been swept up in a sector-wide rotation out of ...

In a volatile market, this dividend growth stock is worth every penny of $1,000

Abbott Labs could rally in a downturn and has a long-term growth catalyst to boot.
AOL

Has the Abbott Laboratories Sell-Off Finally Created an Entry Point?

Whether Abbott Laboratories (NYSE: ABT) stock is at a good entry point depends on your investment horizon and tolerance for near-term uncertainty. The stock has been punished hard in 2026, and the ...

The demand for healthcare is going to continue to accelerate, says Abbott Labs CEO Robert Ford

Robert Ford, Abbott Laboratories chairman and CEO, joins 'Squawk Box' to discuss the state of healthcare demand, the company's nutrition business, growth outlook, and more.
Yahoo

Chicago jury awards millions to families after babies fall ill after consuming Abbott formula

Add Yahoo as a preferred source to see more of our stories on Google. A trial that lasted five weeks is over regarding baby formula made by Illinois-based Abbott Labs. A jury said the result is what ...